SEC 13F Intelligence

Mass General Brigham, Inc / RVMD

Mass General Brigham, Inc’s Revolution Medicines Inc Position

Does Mass General Brigham, Inc own Revolution Medicines Inc (RVMD)? Yes344.1K shares worth $33M (+7.14% of its 13F portfolio) as of Q1 2026.

Position Value
$33M
Q1 2026
Shares
344.1K
% of Portfolio
+7.14%
Quarters Held
7
currently held

Position History RVMD

Reported value by quarter
Q4 ’22: $510Q4 ’22Q1 ’23: $7,325Q1 ’23Q1 ’24: $11MQ1 ’24Q2 ’24: $13MQ2 ’24Q3 ’24: $15MQ3 ’24Q4 ’25: $27MQ4 ’25Q1 ’26: $33MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026344.1K$33M+7.14%
Q4 2025344.1K$27M+3.38%
Q3 2024338.2K$15M+35.15%
Q2 2024338.2K$13M+63.90%
Q1 2024338.2K$11M+19.08%
Q1 2023338.2K$7,325+5.71%
Q4 202221.4K$510+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mass General Brigham, Inc’s full portfolio or all institutional holders of RVMD.